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Perfusion Lung Scintigraphy for the
Diagnosis of Pulmonary Embolism:
A Reappraisal and Review of the Prospective
Investigative Study of Acute Pulmonary
Embolism Diagnosis Methods
Massimo Miniati, MD, PhD,* H. Dirk Sostman, MD,† Alexander Gottschalk, MD,‡
Simonetta Monti, MD, PhD,§ and Massimo Pistolesi, MD*
In this article, we review the evolution of scintigraphy for the diagnosis of acute
pulmonary embolism (PE). We begin with perfusion (Q) scintigraphy, review the devel-
opment of diagnostic systems that combine ventilation (V) scintigraphy and chest
radiography with the Q scan, and describe in detail the Prospective Investigative Study
of Acute Pulmonary Embolism Diagnosis (PISAPED) criteria for diagnostic categoriza-
tion of the Q scan read in conjunction with the chest radiograph. Finally, we review the
results obtained with the PISAPED criteria in clinical research studies. The PISAPED
method for lung scan interpretation provides sensitivity and specificity for diagnosing
acute PE that is comparable to V/Q scanning and to computed tomography angiography
(CTA), with fewer nondiagnostic results than either V/Q or CTA. The criteria can be
used effectively in a diagnostic management approach that incorporates the use of a
clinical prediction rule. Clinical outcomes in patients in whom PE is excluded in this
way are comparable to outcomes for patients in whom the diagnosis is excluded by CTA
or conventional angiography.
Semin Nucl Med 38:450-461 © 2008 Elsevier Inc. All rights reserved.
The Evolution of
Scintigraphy for the Diagnosis
of Acute Pulmonary Embolism
Perfusion Scintigraphy:
The Common Ancestor
In the beginning, there was the Q scan.1-3 A normal Q scanhas long been accepted to exclude pulmonary embolism (PE)
for practical purposes (the morbidity and mortality of
missed PE has been thought to be far less than that from
continuing the diagnostic evaluation or with preemptive
therapy).4,5 It is the Q scan that is pivotal in excluding PE;
as long as Q is normal, the V scan or chest radiograph (CXR)
can be abnormal and the examination is still read as negative
for PE. Excluding PE is an important decision, so it is gener-
ally felt that Q scans should be interpreted conservatively,
and a “normal” diagnosis reserved for unequivocally normal
Q studies. This is because it has been demonstrated experi-
mentally that Q scintigraphy is not perfectly sensitive; in
dogs, the sensitivity of the Q scan is approximately 80% for
emboli that completely occlude pulmonary vessels, but only
approximately 30% for partially occluding emboli.6 A normal
Q scan result stops the workup for PE and diverts attention to
other possibilities. Although it is sensitive, Q scintigraphy has
long been thought not to be specific for PE.7 This is because
all common pulmonary diseases, including neoplasms, infec-
tions, and obstructive airways disease, can produce de-
creased pulmonary blood flow to affected regions.8 To over-
come this perceived problem, Wagner et al9 and DeNardo et
al10 suggested the technological solution of combined V/Q
lung imaging.
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The Profusion of Diagnostic
Approaches Using V/Q Scintigraphy
McNeil and coworkers11 highlighted the findings of numer-
ous investigators by pointing out that abnormalities in the Q
scan that are matched by abnormal ventilation usually are not
caused by pulmonary embolism, whereas mismatched ab-
normalities, coexisting with a normal CXR, have a high cor-
respondence with angiographically demonstrated PE. Alder-
son and coworkers12 later showed that the overall diagnostic
accuracy for scintigraphic detection of pulmonary emboli
was significantly improved when V studies were added to the
Q scan and CXR. Extensive work by Biello and collabora-
tors13,14 further categorized Q defects matched by ventilation
or radiographic abnormalities and provided grounds for re-
ducing the number of “indeterminate” diagnoses. Further
evaluation15 confirmed that this diagnostic approach pro-
vided improved interobserver consistency and a 30% reduc-
tion in “indeterminate” readings compared with the results
from an older system. By the early 1980s, it was accepted that
a scintigraphic study demonstrating multiple large, wedge-
shaped, pleural-based Q defects with normal V and CXR in
the corresponding areas has an extremely high correspon-
dence with PE, hence the term “high probability of PE.”
However, the diagnostic criteria for patterns other than
normal Q and classic “high probability of PE” continued to
evolve. The need for this was emphasized by the results of the
first Prospective Investigation of Pulmonary Embolism Diag-
nosis (PIOPED) study, which showed that the combination
of pretest clinical assessment and V/Q scintigraphy could
diagnose or exclude PE accurately but that such readings
were possible in only 28% of patients.16 Accordingly, with
the best-available V/Q scintigraphic methods, most patients
had diagnostic results that were insufficiently conclusive to
guide definitive clinical management.
Further research was prompted by intriguing data that
indicated some experienced individuals could achieve more
accurate results by using their own subjective assessment
than by using the corresponding reference criteria.17,18 The
PIOPED Nuclear Medicine Working Group revised the
PIOPED criteria,17 and a prospective trial19 determined that,
although they were more accurate than the original PIOPED
criteria, the “gestalt” impression of experienced readers was
still more accurate. Work by Stein and coworkers20,21 helped
in making the criteria for “high probability” easier to apply
and more sensitive. A study by Worsley and coworkers22
indicated that Q/CXR matches in the upper and middle lung
zones have a low likelihood (11-12%) of being associated
with PE in the same zone, whereas those in the lower zones
have a greater likelihood (33%).
The focus of research was primarily aimed at reducing the
number of “nondiagnostic” readings, defined as the sum of
“low-probability” and “intermediate-probability” results.23
The high proportion of nondiagnostic results was the princi-
pal reason for the decline in utilization of V/Q scans during
the late 1990s and early 2000s. The research approach to this
problem has been 2-fold. First, the validation of clinical pre-
diction rules has added information to the diagnostic process
and reduced the burden that previously was carried entirely
by the scan. Second, further refinement of scan interpretation
permitted many patients to be taken out of the “nondiagnos-
tic” category; as mentioned, in PIOPED I, (32% outpatients),
V/Q scans gave a definitive diagnosis in only 28% of pa-
tients.16
Gottschalk and coworkers24 dramatically reduced the
number of “nondiagnostic” readings by demonstrating that a
large subset of “low-probability” scans that are categorized as
“very low probability” can safely be used to exclude PE. A
“very low probability” interpretation of the V/Q scan is as
reliable as computed tomography angiography (CTA) in ex-
cluding PE when the clinical probability is low or moderate.
In other studies, if the CXR was normal or nearly normal, a
definitive reading of the V/Q scan was shown in 91%25 of
patients. However, without the very low probability interpre-
tation, and considering a low probability interpretation as
nondiagnostic, others found a definitive diagnosis by V/Q in
patients with a normal CXR of only 22%26 and 52%.27
Retrospective analysis with recategorization of data from
PIOPED II (75% outpatients) into “PE present,” “PE absent,”
and “nondiagnostic” showed a definitive V/Q scan reading in
74% of patients, with moderate sensitivity and high specific-
ity in the groups with such readings.28 At the same time, a
Canadian randomized clinical trial showed equivalent out-
comes when comparing patients evaluated with a clinical
prediction rule and either CTA or V/Q scintigraphy, although
more patients with PE were detected by CTA.29
Back to Basics: PISAPED
and Re-evaluation of the Q Scan
The Prospective Investigative Study of Acute Pulmonary Em-
bolism Diagnosis (PISAPED) trial combined both approach-
es: incorporation of clinical prediction rules and revised scan
interpretation criteria. The investigators suggested a new set
of diagnostic criteria, intended to diagnose or exclude PE
using the Q scan and CXR30 with few nondiagnostic readings.
In this study, researchers prospectively evaluated 890 con-
secutive patients with suspected PE. Before lung scanning,
each patient was assigned a clinical probability of PE (very
likely, possible, unlikely). Perfusion scans were indepen-
dently classified as follows: (1) normal, (2) near-normal, (3)
abnormal compatible with PE (PE: single or multiple
wedge-shaped Q defects), or (4) abnormal not compatible
with PE (PE: Q defects other than wedge-shaped). The
diagnostic reference standard was pulmonary angiography.
Clinical and scintigraphic follow-up was obtained in all pa-
tients with abnormal scans. Of 890 scans, 220 were classified
as normal/or near-normal and 670 as abnormal. A definitive
diagnosis was established in 563 (84%) patients with abnor-
mal scans. Most patients were inpatients, and the overall
prevalence of PE was 39%. Most patients with angiographi-
cally proven PE had PE scans (sensitivity: 92%). Con-
versely, most patients without emboli on angiography had
PE scans (specificity: 87%). A PE scan associated with a
“very likely” or “possible” clinical presentation of PE had
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positive predictive values of 99% or 92%, respectively. A PE
scan paired with an “unlikely” clinical presentation had a
negative predictive value of 97%. Clinical assessment com-
bined with Q-scan evaluation established or excluded PE in
the majority of patients with abnormal scans. This data sug-
gested that accurate diagnosis of PE is possible by Q scanning
alone, without V imaging. Combining Q scanning with clin-
ical assessment helped to restrict the need for further diag-
nostic evaluation to a minority of patients with suspected PE.
A subgroup analysis of the PIOPED data had also sug-
gested that the V scan was not essential.31 The results of this
prospective study also were corroborated by a retrospective
analysis in which one of the PISAPED investigators re-read
723 Q scans and CXR from the PIOPED I study. The sensi-
tivity was 80% and the specificity 83%, using the PIOPED I
angiographic result as the gold standard.30
Comparative Trial of PIOPED and
PISAPED Criteria for Q Scintigraphy
We used the archived Prospective Investigation of Pulmo-
nary Embolism Diagnosis II (PIOPED II) data and images
to test the hypothesis that reading perfusion (Q) scans
with chest radiographs (CXR) but without ventilation (V)
scans, and categorizing the Q scan as “PE Present” or “PE
Absent” can result in clinically useful sensitivity and spec-
ificity in a high proportion of patients in a new patient
population.
Patients recruited into PIOPED II were eligible for the
study if they had (1) computed tomographic angiography
(CTA) and/or digital subtraction angiography (DSA) diagno-
sis, (2) interpretable Q scan and CXR and (3) prospectively
recorded Wells’32 score. Four readers re-read Q scans with
CXR in eligible patients. Two readers used modified (for the
absence of the V scan) PIOPED criteria and two readers used
the PISAPED criteria. The CXR were read as “normal/near
normal,” “abnormal” or “nondiagnostic” and the Q scans
were read as “PE Present,” “PE Absent” or “Nondiagnostic.”
The primary analysis used a composite reference standard:
(1) the PIOPED II DSA result, or (2) if there was no definitive
DSA result, CTA results that were concordant with the Wells’
score (ie, CTA positive and Wells’ score2, or CTA negative
and Wells’ score 6).
The prevalence of PE in the sample was 169 of 889 (19%).
Using the modified PIOPED criteria, the sensitivity of a “PE
Present” Q scan was 84.9% (95% confidence interval [CI],
80.1-88.8%), whereas the specificity of “PE Absent” was
92.7% (95% CI, 91.1-94.1%), excluding “nondiagnostic” re-
sults, which occurred in 20.6% (95% CI, 18.8-22.5%). Using
the PISAPED criteria, the sensitivity of a “PE Present” Q scan
was 80.4% (95% CI, 75.9-84.3%), and the specificity of “PE
Absent” was 96.6% (95% CI, 95.5-97.4%); however, the pro-
portion of patients with a “Nondiagnostic” scan was 0% (95%
CI, 0.0-0.2%).
These results indicate that Q scintigraphy combined with
chest radiography can provide diagnostic accuracy similar to
that of CTA and V/Q. The additional benefits are lower cost
and lower radiation dose. With modified PIOPED criteria, a
higher proportion of patients were nondiagnostic than the
6.2% rate found in PIOPED II using CTA, whereas with PIS-
APED criteria none were nondiagnostic.
The PISAPED
Criteria and Their Application
in Reading Perfusion Scans
The value of the Q scanning approach compared with V/Q
scanning stems from the flawed assumption that lung regions
excluded from perfusion by emboli maintain a normal ven-
tilation (V/Q mismatch). The V/Q mismatch criterion to di-
agnose PE is at variance with several studies33-37 in which the
authors showed that ventilation is shifted away from embo-
lized lung regions.38 The concept that dead space ventilation
is not significantly increased in the course of PE38 was widely
held in respiratory pathophysiology before the V/Q scanning
approach was developed as it was asserted by Julius H. Com-
roe, Jr, who, in 1966,39 foresaw that: “[T]he decrease in
wasted ventilation (ventilation to unperfused or poorly per-
fused lung) helps the patient but hinders the physician in
diagnosis.” This notion, besides explaining the low diagnos-
tic sensitivity of V/Q scanning and of dead space ventilation
technique, is in keeping with the observation from the
PIOPED trial that about half of the patients with angiographi-
cally proven PE in the lower lung regions had atelectasis
and/or parenchymal areas of increased opacity in the corre-
sponding lung zones.40 Such parenchymal abnormalities are
likely to affect not only perfusion, but also ventilation scan
images.30
Using the PISAPED Criteria
Perfusion lung scintigraphy is, by definition, an image of the
regional distribution of pulmonary blood flow. Therefore,
when examining a Q scan, one should ask the following
questions: (1) is pulmonary blood flow distributed physio-
logically? (2) Is there any structural abnormality of the heart,
mediastinum, pleura, diaphragms, or chest wall that alters
the scintigraphic outline of the lungs? (3) Is there any perfu-
sion defect within the lungs? (4) If so, is the perfusion defect
due to embolic occlusion of the pulmonary vessels or is it due
to a parenchymal disorder?
The Normal Scan
Under physiologic conditions, the blood flow to the lungs is
preferentially distributed to the dependent and dorsal re-
gions (Fig. 1). For many years, it has been thought that such
preferential distribution is caused by the effect of gravity.
Should it be so, there would be a vertical gradient of blood
flow from the apex to base of the lung without any ventral-
to-dorsal gradient. As shown in Figure 1, however, a ventral-
to-dorsal gradient of blood flow is clearly discernible. On the
basis of experiments performed during the last 10 years, it
appears that the regional distribution of blood flow is primar-
ily dictated by the anatomic configuration of the pulmonary
arterial tree that is best described by fractal geometry.41,42
According to PISAPED criteria, a Q scan is rated normal
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whenever the blood flow distribution, observed after the
injection of the radiotracer with the patient in the sitting
position, follows a physiological gradient and no abnor-
malities in the lung shape or true perfusion defects are
observed.
The Near-Normal Scan
A number of thoracic extrapulmonary abnormalities may af-
fect the outline of the lung on Q scintigraphy. Such abnor-
malities are easily seen on the plain CXR, which is a necessary
companion to the Q scan. The structural abnormalities that
may alter the shape of the lungs include enlarged heart or
hilar vessels, widened mediastinum, blunting of costo-
phrenic angles, extensive thickening of the pleura, small
pleural effusion (especially intrafissural), elevated dia-
phragm, or thoracic wall deformity (eg, severe kyphoscolio-
sis). Enlargement of the heart, which is frequent in clinical
practice, creates an impression on the lung parenchyma that
is best seen on the anterior, posterior, and left lateral views of
lung scintigrams (Fig. 2). In patients with severe left heart
valvular disease or long-standing left heart failure, the pul-
monary blood flow is often distributed to the upper and
anterior regions of the lungs (Fig. 3). Such redistribution is
the consequence of an extensive remodeling of the pulmo-
Figure 1 Normal perfusion scans (A) and (B). The pulmonary blood
flow is predominantly distributed to basal and dorsal regions. The
radiotracer was injected with the subject in the sitting position.
Figure 2 Near-normal perfusion scan in a patients with dilated cardio-
myopathy. The enlarged heart determines compression on lung paren-
chyma that is best seen in anterior, posterior, and left lateral views.
Figure 3 Near-normal perfusion scan in a patient with postischemic
chronic left heart failure. (A) The pulmonary blood flow is distrib-
uted predominantly to upper and anterior regions; (B) CXR shows
enlarged heart, dilated upper lobe vessels, and mild interstitial
edema.
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nary vessels in the dependent lung regions, characterized by
medial hypertrophy, intimal proliferation and, ultimately,
fibrotic occlusion of the lumen.43,44 The reduction of the
vascular cross-sectional area in the dependent lung zones
causes a redistribution of blood flow that is linearly related to
the elevation of pulmonary vascular resistance.45 In a physi-
ologic sense, any lung scan with a pathologic distribution of
pulmonary blood flow, such that shown in Figure 3, should
be rated abnormal. However, because there are no obvious
perfusion defects, such a scintigraphic pattern is rated near-
normal according to PISAPED criteria.
The Abnormal Scan
When perfusion defects are seen on the lung scan, the phy-
sician should make every effort to establish whether they are
suggestive of PE or are associated with diseases of the lung
parenchyma. Since the introduction of Q scintigraphy, it be-
came evident that PE can be differentiated from other lung
disorders by the presence of segmental or lobar perfusion
defects.46,47 At that time, the use of rectilinear scanners
equipped with focusing collimators facilitated the identifica-
tion of such abnormalities by virtue of the tomographic prop-
erties of the technique. With the use of gamma-cameras, the
identification of segmental or lobar perfusion defects can be
accomplished with the aid of multiple planar projections or
by means of single-photon emission tomography. Since the
perfusion defects in lung embolism are usually wedge-
shaped, any lung scan showing one or more such defects is
rated positive for PE according to PISAPED criteria. Accord-
ingly, the shape of the perfusion defects is far more important
than their number or size.
Examples of Q scans suggestive of PE are shown in
Figures 4-8. In massive PE, such perfusion defects are
often associated with multiple areas of overperfusion fea-
turing a wedge configuration (Figs. 4-6). Such distinct
areas of overflow—that were observed in some 80% of the
patients with PE in the PISAPED study—are the expres-
sion of the redistribution of blood flow away from the
embolized segments or lobes.
According to PISAPED criteria, any Q defect other than
wedge-shaped should be regarded as negative for PE,
whether or not there is a matching radiographic abnormal-
Figure 4 Abnormal perfusion scan in a patient with acute pulmonary
embolism. Multiple bilateral wedge-shaped defects are seen along
with areas of overperfusion, featuring a wedge configuration.
Figure 5 Abnormal perfusion scan in a patient with acute bilateral
pulmonary embolism.
Figure 6 Abnormal perfusion scan in a patient with acute bilateral
pulmonary embolism.
Figure 7 Abnormal perfusion scan in a patient with acute bilateral
pulmonary embolism.
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ity. Clinical conditions that are associated with perfusion
abnormalities not caused by PE include pneumonia, lung
cancer, alveolar edema, interstitial lung disease, and
chronic obstructive lung disease (COPD). Epidemiological
surveys in samples of the Italian general population indi-
cate that the prevalence of COPD in subjects ages 50 years
or older is approximately 30%.48 Therefore, when one
evaluates lung scans from elderly patients, COPD should
be taken into account as a potential cause of the perfusion
abnormalities. In this connection, the CXR may prove use-
ful because it provides criteria for diagnosing moderate-
to-severe emphysema.49 Perfusion lung scans from pa-
tients with COPD and no obvious emphysema are shown
in Figures 9-11.
Examples of lung scans from patients with COPD and
emphysema of varying degree of severity are given in Figures
12-16. In COPD, the Q scan may show a variety of abnor-
malities ranging from diffuse inhomogeneities to bilateral
nonsegmental perfusion defects that are often symmetric in
distribution. When emphysema is present, the outline of the
lungs is poorly defined, especially along the upper regions.
As emphysema becomes extensive, large unperfused areas
are seen, which span from the apex to the base of the lung. In
the most severe forms, only a small band of perfused lung
tissue is left around the heart and over the diaphragms (Figs.
15 and 16). Such extensive perfusion abnormalities should
not make the physician interpret the scan as nondiagnostic
for PE for, if emboli were present, they would be distributed
in those regions where the perfusion is still preserved. The
Figure 8 Abnormal perfusion scan in a patient with acute pulmonary
embolism. Perfusion is absent in the right lower lobe. A small
wedge-shaped perfusion defect is seen in the lingula (A). Coronal
CTA image (B) shows vascular obstruction by embolism.
Figure 9 Abnormal perfusion scan in a patient with COPD. (A) Bi-
lateral nonsegmental perfusion defects; (B) posteroanterior CXR
shows increased bronchovascular markings but no signs of emphy-
sema.
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scintigraphic diagnosis of PE in patients with COPD is un-
doubtedly difficult. However, when the PISAPED criteria are
strictly applied, segmental defects can be identified in the
context of diffuse perfusion inhomogeneities. An example of
PE in COPD is shown in Figure 17. Perfusion defects associ-
ated with bilateral pneumonia and lung cancer are displayed
in Figures 18 and 19.
Combining
Perfusion Scintigraphy
With Pretest Probability of PE
The results of prospective studies support the concept that
clinical probability assessment is a fundamental step in the
diagnosis of PE. The strategy of combining Q scan inter-
pretation with independent evaluation of clinical proba-
bility was tested in a management study including 390
patients with suspected PE.50 The pretest probability of PE
was rated according to a standardized clinical prediction
model.51 Pulmonary embolism was considered present in
patients with abnormal scans suggestive of PE and a pre-
test probability 50%. Patients with normal or near-nor-
mal scans and those with abnormal scans not suggestive of
PE with a pretest probability 10% were deemed not to
have PE. All other patients were allocated to pulmonary
angiography. All the patients were followed up for 1 year.
PE was diagnosed noninvasively in 132 patients (34%)
and excluded in 191 (49%). Pulmonary angiography was
required in 67 of the 390 patients (17%). Therefore, the
diagnostic yield of the noninvasive strategy was 83% (95%
Figure 10 Abnormal perfusion scan in a patient with COPD.
(A) Bilateral nonsegmental perfusion defects; (B) posteroanterior
and lateral CXRs show no signs of emphysema.
Figure 11 Abnormal perfusion scan in a patient with COPD.
(A) Bilateral nonsegmental perfusion defects; (B) posteroanterior
and lateral CXRs show no signs of emphysema.
Figure 12 Abnormal perfusion scan in a patient with COPD and mild
emphysema. (A) Perfusion is reduced in upper lung regions where
the outline of the lungs is poorly defined; (B) posteroanterior and
lateral CXRs show reduced vascularity and hyperlucency in upper
lung lobes.
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CI, 79-86%). The patients in whom PE was excluded had
a 1-year thromboembolic risk of 0.4% (95% CI, 0-2.8%).
Combining Q scintigraphy with independent assessment
of the clinical probability of PE may prove particularly
useful in women of childbearing age who may be at risk of
breast cancer when exposed to the substantial radiation
burden associated with extensive use of CTA.
Perfusion Scintigraphy
in the Follow-Up of PE
The rationale of following over time patients with an estab-
lished diagnosis of PE is 2-fold: (1) to assess the restoration of
pulmonary perfusion, and (2) to identify patients with per-
sistent large perfusion defects who may be at risk of develop-
ing chronic thromboembolic pulmonary hypertension. Per-
fusion scintigraphy offers a number of advantages over CTA
for this purpose. It is less expensive, entails a substantially
lower radiation burden, and provides an overall view of the
regional distribution of pulmonary blood flow, thereby per-
mitting the identification of very small perfusion abnormali-
ties. In a recent study, including 320 patients with angio-
graphically confirmed PE, Q scans were obtained at
diagnosis, and at 1 week, 1 month, and 1 year of inclusion.52
The median extent of scintigraphically detectable pulmonary
vascular occlusion at diagnosis was 43% (range, 5-82%).
Most of the patients who survived a full year after PE showed
near-complete restoration of pulmonary perfusion along
with considerable improvement in arterial oxygenation. Only
Figure 13 Abnormal perfusion scan in a patient with COPD and
moderate emphysema. (A) The scintigraphic outline of the lungs is
ill-defined with non segmental bilateral perfusion defects predom-
inantly in upper lung regions; (B) posteroanterior and lateral CXRs
show clear signs of emphysema predominantly in upper lung lobes.
Figure 14 Abnormal perfusion scan in a patient with COPD and
severe emphysema. (A) Large, symmetric nonsegmental perfusion
defects extend from apical to basal and anterior lung regions;
(B) posteroanterior and lateral CXR show large areas of emphyse-
matous tissue destruction.
Figure 15 Abnormal perfusion scan in a patient with COPD and very
severe bullous emphysema. (A) The scintigraphic outline of the
lungs is not discernible, and the perfusion is preserved only in the
parenchyma around the heart and over the diaphragms; (B) pos-
teroanterior and lateral CXRs show extensive bullous emphysema.
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4 (1%) of the 320 patients with PE at presentation developed
chronic thromboembolic pulmonary hypertension. All these
patients featured persistent large perfusion defects in sequen-
tial scintigrams. Therefore, monitoring the resolution of PE
by lung scanning is a practical and relatively inexpensive
means to identify patients with persistent perfusion abnor-
malities who may be at risk of chronic thromboembolic pul-
monary hypertension.
Role of CXR
The CXR is considered by most investigators not to be an
accurate means of diagnosing PE.53 Most patients with PE
have abnormal CXR, but the CXR changes are generally
considered nonspecific. Common findings include consol-
idation, various manifestations of atelectasis, pleural effu-
sion (usually small), and diaphragmatic elevation. Less
common findings include nodules, focal oligemia, proxi-
mal pulmonary artery enlargement and acute heart failure.
Some diagnostic signs (particularly focal oligemia or
changes in proximal pulmonary artery size) can be subtle
and difficult to interpret unless high quality comparison
films are available.
However, the CXR is an essential component in the eval-
uation of a patient clinically suspected of having PE. The CXR
is needed to establish or exclude clinical mimics of PE such as
pneumonia, rib fracture or pneumothorax. It is also essential
for adequate evaluation of the lung scintigram, particularly
when the V scan is omitted. One should obtain a high quality
PA and lateral examination at the same time as the lung scan.
Portable AP films are a poor substitute, and if a portable film
must be used, the patient’s position should be accurately
recorded so that account may be made for layering of pleural
fluid. Chest radiographs more than a few hours old are also
suboptimal.
It has long been thought that the CXR provides informa-
tion that is complementary and important to the interpreta-
tion of the Q scan.47 This is of particular note with the PIS-
APED criteria. When using the PISAPED criteria, in
examining the CXR, the reader must consider the following
items: size and shape of the heart and hilar arteries, position
of the diaphragm, presence or absence of pulmonary paren-
chymal abnormalities (consolidation, atelectasis, oligemia,
edema), and pleural effusion. On evaluating the hilar arteries,
attention is paid to the presence of abrupt vascular amputa-
tion that gives the hilum a “plump” appearance.51 Pulmonary
consolidations are considered suggestive of infarction if they
have a semicircular or half-spindle shape and are arranged
peripherally along the pleural surface.51 Oligemia is consid-
ered to be present if, in a given lung region, the pulmonary
vasculature is greatly diminished with or without concomi-
tant hyperlucency of the lung parenchyma.51 Chest radio-
graphs are rated as abnormal if one or more of the following
are present: enlargement of the heart or hilar vessels; elevated
Figure 17 Acute pulmonary embolism in a patient with COPD.
(A) wedge-shaped perfusion defects are seen in the right lung (ar-
rows); (B) coronal and sagittal CTA images show multiple arterial
filling defects.
Figure 16 Abnormal perfusion scan in a patient with COPD and very
severe panlobular emphysema. (A) The perfusion abnormalities are
similar to those of Figure 15; (B) posteroanterior and lateral CXRs
show extensive emphysema.
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diaphragm (unilateral or bilateral); pleural effusion (includ-
ing intrafissural liquid); increased lung density (focal or dif-
fuse); pulmonary edema; oligemia with or without pleonexia
in the contralateral lung; consolidation suggestive of infarc-
tion; emphysema; fibrothorax.
These observations, instead of being used simply to con-
sider the CXR as abnormal, can be used to increase or reduce
the clinical likelihood of PE.51 Furthermore it has to be
stressed that in the PISAPED reading of the Q scan the CXR is
not used as a surrogate of the ventilation scan. In fact, the
shape of the Q scan defects (wedge shaped or not) that de-
termines the scintigraphic diagnosis is judged irrespective of
the radiographic findings in the corresponding lung regions.
This prevents the possible increase in nondiagnostic results
that could derive from interpreting perfusion defects and
radiographic increased density as matching defects (eg, in the
modified PIOPED criteria).27
Conclusion
It might appear that pulmonary scintigraphy for acute PE has
traversed a circular path, arriving after 40 years of research
back at its point of origin with a recommendation for using Q
scans and CXR for diagnostic evaluation. This would be su-
perficially correct, but would miss more important perspec-
tives.
First, it should be acknowledged that, in some individ-
ual cases, V scans may be helpful in arriving at a diagnosis;
in such cases, they can be obtained after the Q scan and
CXR are performed. Second, the task of imaging is now
more focused because of important developments in clin-
ical evaluation (the validation of clinical prediction rules)
and laboratory testing (D-dimer measurement) have en-
abled more accurate assessment of pretest probability, and
the information content of the diagnostic process thus has
been enhanced. Third, the basis and correlates of disease
on the Q scan are now better understood as a result of
decades of clinical research. Accordingly, the apparently
naïve simplicity we now observe is actually the simplicity
of sophistication, due to elimination of superfluous ele-
ments. Finally, the cost and patient safety perspectives
have been firmly entrenched in the diagnostic and patient
management value calculus.
Further work will be needed to confirm and extend the
results obtained to date with the PISAPED criteria. It re-
mains to be proven that these criteria can be taught to, and
employed by, new observers who do not have years of
experience correlating clinical, imaging and diagnostic
outcome data. We do not yet understand how influential
the findings on the CXR may be in using the Q scan with
this system in such settings, nor how the CXR findings can
be incorporated systematically and objectively. We need
Figure 18 Bilateral pneumonia. (A) Nonsegmental perfusion defects
are seen in the upper lung lobes; (B) posteroanterior CXR shows
bilateral opacities in the upper lobes.
Figure 19 Lung cancer in a patient with no history of COPD. (A) a
single nonsegmental perfusion defect is seen in the posterior regions
of the right lung; (B) posteroanterior and lateral CXRs show a
rounded sharply defined opacity in the costo-vertebral region of the
right lung.
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to document that patient outcomes are satisfactory in a
large number of patients with a wide spectrum of disease
when managed according to the diagnostic results of this
method, but with multiple new readers. Finally, it is pos-
sible that some hybrid of the modified PIOPED and
PISAPED classification systems might further improve on
the results thus far obtained with each of them individu-
ally, and this should be investigated.
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